Sensei biotherapeutics to participate in the piper sandler 34th annual healthcare conference

Boston, nov. 22, 2022 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that john celebi, president and chief executive officer, will participate in a fireside chat at the piper sandler 34th annual healthcare conference, being held in new york, ny, on thursday, december 1, 2022, at 2:00 p.m. et.
SNSE Ratings Summary
SNSE Quant Ranking